Sandoz Private Limited Olaparib Export Data — India (DGFT 2022–2026)

Name: Sandoz Private Limited Olaparib Export Records India — #2 Exporter, 57 Shipments, $161.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Olaparib

India Pharmaceutical Trade Intelligence

$922.2K70 Suppliers49 CountriesHS 30049099

ExportsIndia → RUSSIA29.1%India → SLOVENIA17.6%

ImportsPUERTO RICO → India$85.9M UNITED KINGDOM → India$1.4M

#1 Supplier: BDR PHARMACEUTICALS

Sandoz Private Limited — Olaparib Exporter #2 | $161.9K Trade Value | TransData Nexus | TransData Nexus

Sandoz Private Limited — Olaparib Exporter Profile

Indian Pharmaceutical Exporter · #2 for Olaparib · $161.9K export value · DGFT Verified

Sandoz Private Limited is the #2 Indian exporter of Olaparib with $161.9K in export value and 57 verified shipments. Sandoz Private Limited holds a 17.6% market share in Olaparib exports across 2 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.

Sandoz Private Limited — Olaparib Export Profile: Buyers & Destinations

Sandoz Private Limited Olaparib export treemap — buyers and destination countries | TransData Nexus

Where Does Sandoz Private Limited Export Olaparib?

Country	Value	Shipments	Share
SLOVENIA	$161.9K	55	100.0%
SOUTH AFRICA	$33	2	0.0%

Sandoz Private Limited exports Olaparib to 2 countries. The largest destination is SLOVENIA accounting for 100.0% of Sandoz Private Limited's Olaparib shipments. These destinations reflect Sandoz Private Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Olaparib from Sandoz Private Limited?

Buyer

What Olaparib Formulations Does Sandoz Private Limited Export?

Product Description / Formulation	Value	Shipments
OLAPARIB FCT 150MG B/N: 32377858 (120 TA	$20.9K	2
OLAPARIB FCT 100MG B/N: 32380402 (120 TA	$14.0K	2
OLAPARIB FCT 150MG B/N: 32378842 (120 TA	$13.4K	2
OLAPARIB FCT 150MG B/N: 32377857 (60 TAB	$12.7K	2
OLAPARIB FCT 100MG B/N: 32380489 (120 TA	$9.0K	2
OLAPARIB FCT 150MG B/N: 32376589 (120 TA	$9.0K	2
OLAPARIB FCT 100MG B/N: 32380401 (60 TAB	$8.5K	2
OLAPARIB FCT 150MG (COATED TABLETS), B/N	$6.9K	1
OLAPARIB FCT 100MG B/N: 32380165 (120 TA	$6.0K	2
OLAPARIB FCT 150MG (EXTRUDATE +BLEND), B	$5.9K	1

Sandoz Private Limited exports 39 distinct Olaparib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OLAPARIB FCT 150MG B/N: 32377858 (120 TA with 2 shipments worth $20.9K.

How Does Sandoz Private Limited Compare to Nearest Olaparib Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED	$285.6K	15	2	$19.0K
2	SANDOZ PRIVATE LIMITED ★	$161.9K	57	2	$2.8K
3	VAMA HEALTH WORLD LLP	$107.6K	20	2	$5.4K
4	SPECIALITY MEDICINES LIMITED	$76.4K	15	2	$5.1K

Sandoz Private Limited ranks #2 among 70 Indian Olaparib exporters. Average shipment value of $2.8K compared to the market average of $11.2K. The closest competitors by value are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED and VAMA HEALTH WORLD LLP.

Which Indian Ports Ship Olaparib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	120	39.1%
SAHAR AIR	56	18.2%
HYDERABAD ACC (INHYD4)	17	5.5%
Bombay Air Cargo	17	5.5%
AHEMDABAD AIR ACC (INAMD4)	16	5.2%
Bombay Air	12	3.9%
HYDERABAD AIR	9	2.9%
Hyderabad Air	8	2.6%

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Olaparib Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.

Sandoz Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.

The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Olaparib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 57 individual customs records matching Sandoz Private Limited exporting Olaparib, covering 39 formulations to 2 countries via 5 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 49+ countries, 99+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

LEK PHARMACEUTICALS D.D.	SLOVENIA	$159.9K	50
LEK PHARMACEUTICALS DD	SLOVENIA	$1.3K	2
SDC SLOVENIA	SLOVENIA	$696	1
PIJA KOSIR	SLOVENIA	$53	2
DSV HEALTHCARE (PTY) LIMITED	SOUTH AFRICA	$33	2

Olaparib

Olaparib

Sandoz Private Limited — Olaparib Exporter Profile

Sandoz Private Limited — Olaparib Export Profile: Buyers & Destinations

Where Does Sandoz Private Limited Export Olaparib?

Who Are the Top Buyers of Olaparib from Sandoz Private Limited?

What Is India's Total Olaparib Export Value and How Much Does Sandoz Private Limited Contribute?

What Is the Average Shipment Value for Sandoz Private Limited's Olaparib Exports?

How Does Sandoz Private Limited Compare to Other Indian Olaparib Exporters?

What Olaparib Formulations Does Sandoz Private Limited Export?

Regulatory Requirements: Exporting Olaparib to Key Markets

South Africa — SAHPRA

How Does Sandoz Private Limited Compare to Nearest Olaparib Exporters?

Which Indian Ports Ship Olaparib Exports?

What Other Advanced Oncology Products Does Sandoz Private Limited Export?

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Olaparib Exports

Sandoz Private Limited — Regulatory Compliance & Quality Standards

About Sandoz Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Olaparib Export Data from Sandoz Private Limited

Olaparib Stats

Company Overview

Top Products by Sandoz Private Limited

Related Analysis

Need Detailed Export Data?

Data Source